EPISODE · May 21, 2026 · 20 MIN
Discussing Scleroderma: Clinical efficacy of tofacitinib and neutrophil dysregulation in SSc
from Scleroderma Forum · host Scleroderma Forum
Professor Francesco Del Galdo and Professor Yannick Allanore discuss two recent studies advancing the treatment landscape in scleroderma. This episode discusses tofacitinib efficacy and neutrophil-driven vasculopathy in SSc. Through expert-led discussion, this podcast offers practical perspectives for clinicians looking to stay at the forefront of scleroderma care. To explore the full papers and download accompanying slide decks, visit the Scleroderma Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: www.scleroderma-forum.com
What this episode covers
Professor Francesco Del Galdo and Professor Yannick Allanore discuss two recent studies advancing the treatment landscape in scleroderma. This episode discusses tofacitinib efficacy and neutrophil-driven vasculopathy in SSc. Through expert-led discussion, this podcast offers practical perspectives for clinicians looking to stay at the forefront of scleroderma care. To explore the full papers and download accompanying slide decks, visit the Scleroderma Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: www.scleroderma-forum.com
NOW PLAYING
Discussing Scleroderma: Clinical efficacy of tofacitinib and neutrophil dysregulation in SSc
No transcript for this episode yet
Similar Episodes
Jul 15, 2026 ·31m
Jul 8, 2026 ·43m
Jul 8, 2026 ·30m
Jul 1, 2026 ·27m
Jun 24, 2026 ·29m
Jun 24, 2026 ·35m